Human Psychopharmacology-Clinical and Experimental

Papers
(The TQCC of Human Psychopharmacology-Clinical and Experimental is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
31
30
The prevalence of constipation in adult psychiatric out‐patients on clozapine treatment at a regional public hospital in Hong Kong29
Clinical predictors of depressive symptom remission and response after racemic ketamine and esketamine infusion in treatment‐resistant depression17
Bupropion and Anxiety: A Brief Review11
Effect of fasedienol (PH94B) pherine nasal spray and steroidal hormones on electrogram responses and autonomic nervous system activity in healthy adult volunteers11
A diffusion tensor imaging study in schizophrenia patients with clozapine induced obsessive compulsive symptoms11
9
A Naturalistic Examination of the Acute Effects of High‐Potency Cannabis on Emotion Regulation Among Young Adults: A Pilot Study9
Effects of the active botanical blend “WKUP GT” on attention and cognitive functions after lunch in healthy volunteers8
Becoming More Precise in Psychiatry: Signposts, Destinations, Maps and Territories8
Factors influencing concentrations of risperidone and 9‐hydroxyrisperidone in psychiatric outpatients taking immediate‐release formulations of risperidone8
7
Issue Information7
Reply to: 5‐MeO‐DMT has not been found in traditional ayahuasca preparations and the combination of 5‐MeO‐DMT with MAOIs is dangerous7
Effects of COVID‐19 Lockdowns on Alcohol Consumption, Hangovers and Smoking Among Young Adults ( n  = 140) in Germany: An On‐Line Study7
Could R‐Ketamine and Wolfram Syndrome Inform Understanding of Depression and Suicidality? A Sigma‐1 Receptor‐Based Perspective7
Efficacy and safety of hydroxyzine for sleep in adults: Systematic review7
Efficacy and safety of lemborexant as an alternative drug for patients with insomnia taking gamma‐aminobutyric acid–benzodiazepine receptor agonists or suvorexant6
Issue Information6
Hypothalamic‐pituitary‐adrenal and autonomic response to psychological stress in abstinent alcohol use disorder individuals with and without depressive symptomatology6
Issue Information6
Analysis of schizophrenia‐associated genetic markers in the HLA region as risk factors for tardive dyskinesia5
Issue Information4
Safety and efficacy of Withania somnifera for anxiety and insomnia: Systematic review and meta‐analysis4
Corrigendum4
Dexamphetamine increased speech and visual unimodal illusions in healthy participants without affecting temporal binding window4
Billy Mackenzie: Sometimes Wild, Often Lonely3
Alcohol Consumption During the COVID‐19 Pandemic: A Critical Review3
Facilitated extinction of conditioned fear responses by delta 9‐tetrahyrdrocannabidol in humans: a pilot study3
Efficacy and acceptability of adjunctive n‐acetylcysteine for psychotic disorders: Systematic review and meta‐analysis3
Nx4 attenuated stress‐induced activity of the anterior cingulate cortex—A post‐hoc analysis of a randomized placebo‐controlled crossover trial3
Nick Drake: A Troubled Mind, a Troublesome ‘Cure’3
Immunomodulatory Potential of Escitalopram on C‐C Motif Chemokine Ligand 5 and Fibroblast Growth Factor 2 in Patients With Generalised Anxiety Disorder3
3
The impact of adjunctive aripiprazole on QT interval: A 12‐week open label study in patients on olanzapine, clozapine or risperidone3
0.53331398963928